Back to CGEM

Elmind Capital, LP → CGEM

Elmind Capital, LP CGEM Position History

Cullinan Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$14.8M
Q3 2026
Peak value
$14.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$3.2M
Q1 2026$7.5M
Q2 2026$12.6M
Q3 2026$14.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$14.8M962.8K——
Q2 2026$12.6M690.0K——
Q1 2026$7.5M530.0K——
Q4 2025$3.2M310.0K——

Other funds holding CGEM

Other Elmind Capital, LP positions

COGT

COGENT BIOSCIENCES INC

$45.3M
COGT

COGENT BIOSCIENCES INC

$45.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$43.3M
COGT

COGENT BIOSCIENCES INC

$41.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$40.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$39M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36.8M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36M